Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Cancer survivorship: surgery and multimodality treatment for the patient's quality of life

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 21 Sep 2009

Views: 16691

Rating:

Save

Professor Peter Schlag - University Medicine Berlin, Germany

Professor Peter Schlag, Surgical Research Unit, Max-Delbrueck-Centrum and Robert-Roessle-Klinik, Charité - University Medicine Berlin, Berlin, Germany: Cancer survivorship – surgery and multimodality treatment for the patient's quality of life, German Language press conference from ECCO 15 ESMO 34 Berlin, 2009.

Related Videos

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Choosing Wisely for young women with breast cancer: Radiotherapy

Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India

Choosing Wisely for young women with breast cancer: Radiotherapy ( Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India )

Cancer mutation prediction using artificial intelligence

Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA

Cancer mutation prediction using artificial intelligence ( Dr Carlo Bifulco - Providence Cancer Institute, Southfield, USA )

ESMO 2024: Optimising the personalisation of prostate cancer treatment

Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg

ESMO 2024: Optimising the personalisation of prostate cancer treatment ( Prof Alison Birtle, Dr Alejo Rodríguez-Vida, Dr Pasquale Rescigno and Prof Gunhild von Amsberg )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Best practice in HRRm testing in patients with metastatic prostate cancer

Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis

Best practice in HRRm testing in patients with metastatic prostate cancer ( Prof Martin Schostak, Dr Alexander Wyatt, Prof Charles Ryan and Dr Emmanuel Antonarakis )

Looking at real world evidence on PSA testing in prostate cancer

Dr Friederike Schlurmann, Prof Boris Hadaschik and Prof Karim Fizazi

Looking at real world evidence on PSA testing in prostate cancer ( Dr Friederike Schlurmann, Prof Boris Hadaschik and Prof Karim Fizazi )

Africa's Medical Physics Workforce

Prof Chris Trauernicht - Tygerberg Hospital, Cape Town, South Africa

Africa's Medical Physics Workforce ( Prof Chris Trauernicht - Tygerberg Hospital, Cape Town, South Africa )

More from ecancer